Stem cell agency lists own board members with conflicts of interest
By David Jensen,
Capitol Weekly
| 08. 24. 2022
In a first in its 18-year history, the California stem cell agency has begun posting on its website a list of its governing board members who have conflicts of interest as they award hundreds of millions of dollars.
The most recent example comes next Tuesday in a $48 million round that will benefit at least 16 public and private colleges in the Golden State and up to 400 students at a cost of $58,220 each.
The latest list shows that 25 members of CIRM’s 35-member governing board have conflicts in the round to be considered Tuesday.
The public conflict postings reflect an awareness of the need for transparency at the $12 billion agency, officially known as the California Institute for Regenerative Medicine (CIRM). The research effort was created by voters in 2004 via a ballot initiative, Proposition 71. The measure gave many of the potential beneficiaries a seat at the table where the money is handed out.
Since CIRM’s inception, about 80 percent of its awards — now totaling $3 billion — have gone to institutions that have...
Related Articles
By Carl Zimmer and Marco Hernandez , The New York Times | 07.01.2026
Scientists have long dreamed of discovering the alchemy by which chemicals can be turned into life. On Wednesday, a team at the University of Minnesota announced that it had taken a major step toward that vision.
Blending together dozens of...
By Marisa Flook , BioNews | 06.29.2026
An anti-ageing gene therapy not approved by the US Food and Drug Administration (FDA) is set to be offered by an American company at overseas clinics outside of US jurisdiction.
The treatment, developed by Minicircle from Austin, Texas, uses a...
By Ed Pilkington, The Guardian | 06.12.2026
Desperate US parents paying up to $20,000 a session for a procedure scientists say could be bogus
Autistic children as young as 18 months old are being injected with human stem cells derived from umbilical cords in unapproved, unproven and...
By Tobi Thomas, The Guardian | 06.10.2026
The UK’s stem cell transplant system is potentially putting the lives of blood cancer patients at risk as a result of inadequate infrastructure and a lack of long-term planning, a parliamentary report has found.
A hematopoietic stem cell transplant, often...